SHH and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, resveratrol inhibited both Shh signaling and Bcr-Abl expression in human chronic myeloid leukemia (CML) cells, indicating that resveratrol may have potential as a treatment for CML [10].